Novavax, Inc. Profile Avatar - Palmy Investing

Novavax, Inc.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine …

Biotechnology
US, Gaithersburg [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Novavax, Inc. has no acquisition track records yet.

M&A Deals · History

Novavax, Inc. has no acquisition track records yet.

End of NVAX's Analysis
CIK: 1000694 CUSIP: 670002401 LEI: - UEI: -
Secondary Listings